Literature DB >> 2491016

Genetic studies of human apolipoproteins. X. The effect of the apolipoprotein E polymorphism on quantitative levels of lipoproteins in Nigerian blacks.

B Sepehrnia1, M I Kamboh, L L Adams-Campbell, C H Bunker, M Nwankwo, P P Majumder, R E Ferrell.   

Abstract

Human apolipoprotein E exhibits genetic polymorphism in all populations examined to date. By isoelectric focusing and immunoblotting, three common alleles have been demonstrated in 365 unrelated Nigerian blacks. Furthermore, the APO E genetic polymorphism's effect on quantitative levels of lipids and lipoproteins has been determined. The respective frequencies of the APO E*2, APO E*3, and APO E*4 alleles are .027, .677, and .296. The effect of APO E polymorphism is significant only on total cholesterol and low-density lipoprotein cholesterol. The average excesses of the APO E*2 allele are to lower total cholesterol and low-density lipoprotein cholesterol by 9.19 mg/dl and 11.11 mg/dl, respectively. The average excesses of the APO E*4 allele are to increase total cholesterol and low-density lipoprotein cholesterol by 5.64 mg/dl and 6.18 mg/dl, respectively. On the basis of the differences in (a) the distribution of APO E allele frequencies between the Nigerians and other populations and (b) dietary lipids, we propose a model that shows that lipid metabolism is influenced by the combined effects of the APO E polymorphism and environmental factors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2491016      PMCID: PMC1683508     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  28 in total

1.  Rate and equilibrium constants for binding of apo-E HDLc (a cholesterol-induced lipoprotein) and low density lipoproteins to human fibroblasts: evidence for multiple receptor binding of apo-E HDLc.

Authors:  R E Pitas; T L Innerarity; K S Arnold; R W Mahley
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

2.  Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man.

Authors:  G Utermann; M Hees; A Steinmetz
Journal:  Nature       Date:  1977-10-13       Impact factor: 49.962

3.  A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol.

Authors:  G R Warnick; J J Albers
Journal:  J Lipid Res       Date:  1978-01       Impact factor: 5.922

4.  Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins.

Authors:  T L Innerarity; R W Mahley
Journal:  Biochemistry       Date:  1978-04-18       Impact factor: 3.162

5.  Polymorphism of apolipoprotein E. I. Methodological aspects and diagnosis of hyperlipoproteinemia type III without ultracentrifugation.

Authors:  G Utermann; G Albrecht; A Steinmetz
Journal:  Clin Genet       Date:  1978-12       Impact factor: 4.438

6.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

7.  Enzymatic determination of total serum cholesterol.

Authors:  C C Allain; L S Poon; C S Chan; W Richmond; P C Fu
Journal:  Clin Chem       Date:  1974-04       Impact factor: 8.327

8.  Functional unit of the low density lipoprotein receptor of fibroblasts: a 100,000-dalton structure with multiple binding sites.

Authors:  T L Innerarity; E S Kempner; D Y Hui; R W Mahley
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

9.  Receptor binding of cholesterol-induced high-density lipoproteins containing predominantly apoprotein E to cultured fibroblasts with mutations at the low-density lipoprotein receptor locus.

Authors:  T L Innerarity; R E Pitas; R W Mahley
Journal:  Biochemistry       Date:  1980-09-02       Impact factor: 3.162

10.  Abnormal in vivo metabolism of apolipoprotein E4 in humans.

Authors:  R E Gregg; L A Zech; E J Schaefer; D Stark; D Wilson; H B Brewer
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

View more
  6 in total

1.  Interaction of apolipoprotein E genotype and dietary cholesterol in determining plasma cholesterol levels.

Authors:  R E Ferrell; M I Kamboh
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

2.  Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City.

Authors:  M X Tang; G Maestre; W Y Tsai; X H Liu; L Feng; W Y Chung; M Chun; P Schofield; Y Stern; B Tycko; R Mayeux
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

3.  The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations.

Authors:  D M Hallman; E Boerwinkle; N Saha; C Sandholzer; H J Menzel; A Csázár; G Utermann
Journal:  Am J Hum Genet       Date:  1991-08       Impact factor: 11.025

4.  High frequency of the apo epsilon 4 allele in Khoi San from South Africa.

Authors:  C Sandholzer; R Delport; H Vermaak; G Utermann
Journal:  Hum Genet       Date:  1995-01       Impact factor: 4.132

5.  APOE genotype affects black-white responses of high-density lipoprotein cholesterol subspecies to aerobic exercise training.

Authors:  Thomas O Obisesan; Robert E Ferrell; Andrew P Goldberg; Dana A Phares; Tina J Ellis; James M Hagberg
Journal:  Metabolism       Date:  2008-12       Impact factor: 8.694

6.  Analysis of apolipoprotein E genetic polymorphism in a large ethnic Hakka population in southern China.

Authors:  Zhixiong Zhong; Heming Wu; Hesen Wu; Pingsen Zhao
Journal:  Genet Mol Biol       Date:  2018-11-29       Impact factor: 1.771

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.